Literature DB >> 14764450

Bacterial activation of beta-catenin signaling in human epithelia.

Jun Sun1, Michael E Hobert, Anjali S Rao, Andrew S Neish, James L Madara.   

Abstract

The mucosal lining of the human intestine is constantly bathed in a milieu of commensal gut flora, the vast majority of these being nonpathogenic microorganisms. Here, we demonstrate that microbial-epithelial cell interactions not only affect proinflammatory pathways but also influence beta-catenin signaling, a key component in regulating epithelial cell proliferation. The nonpathogenic Salmonella strain PhoP(c) activates the beta-catenin signaling pathway of human epithelia via a blockade of beta-catenin degradation. Normal beta-catenin ubiquitination necessary for constitutive beta-catenin degradation is abolished, allowing the accumulation and translocation of beta-catenin to the nucleus. Transcriptional activation mediated by the beta-catenin/T cell factor complex increases c-myc expression and enhances cell proliferation. We also show that the Salmonella effector protein AvrA is involved in modulating this beta-catenin activation. These data suggest that nonvirulent bacterial-epithelial interactions can influence beta-catenin signaling and cell growth control in a manner previously unsuspected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764450     DOI: 10.1152/ajpgi.00498.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  55 in total

1.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Bacterial protein AvrA stabilizes intestinal epithelial tight junctions via blockage of the C-Jun N-terminal kinase pathway.

Authors:  Yongguo Zhang; Shaoping Wu; Jun Ma; Yinglin Xia; Xun Ai; Jun Sun
Journal:  Tissue Barriers       Date:  2015-04-03

Review 3.  Exploitation of the ubiquitin system by invading bacteria.

Authors:  Olivia Steele-Mortimer
Journal:  Traffic       Date:  2010-11-24       Impact factor: 6.215

4.  Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination.

Authors:  Zhongde Ye; Elaine O Petrof; David Boone; Erika C Claud; Jun Sun
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

5.  Vitamin D receptor pathway is required for probiotic protection in colitis.

Authors:  Shaoping Wu; Sonia Yoon; Yong-Guo Zhang; Rong Lu; Yinglin Xia; Jiandi Wan; Elaine O Petrof; Erika C Claud; Di Chen; Jun Sun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-09       Impact factor: 4.052

6.  Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation.

Authors:  Patricia W Lin; Loren E S Myers; Laurie Ray; Shuh-Chyung Song; Tala R Nasr; Andrew J Berardinelli; Kousik Kundu; Niren Murthy; Jason M Hansen; Andrew S Neish
Journal:  Free Radic Biol Med       Date:  2009-08-03       Impact factor: 7.376

7.  Wnt2 inhibits enteric bacterial-induced inflammation in intestinal epithelial cells.

Authors:  Xingyin Liu; Rong Lu; Shaoping Wu; Yong-Guo Zhang; Yinglin Xia; R Balfour Sartor; Jun Sun
Journal:  Inflamm Bowel Dis       Date:  2011-06-14       Impact factor: 5.325

Review 8.  Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates.

Authors:  Javier E Irazoqui; Jonathan M Urbach; Frederick M Ausubel
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

9.  Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway.

Authors:  Xingyin Liu; Rong Lu; Shaoping Wu; Jun Sun
Journal:  FEBS Lett       Date:  2010-01-19       Impact factor: 4.124

10.  Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.

Authors:  Yong-Guo Zhang; Rong Lu; Yinglin Xia; David Zhou; Elaine Petrof; Erika C Claud; Jun Sun
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.